HEAL DSpace

Glutathione transferases in drug discovery and development: Towards safer and efficacious drugs

Αποθετήριο DSpace/Manakin

Εμφάνιση απλής εγγραφής

dc.contributor.author Skopelitou, K en
dc.contributor.author Platis, D en
dc.contributor.author Axarli, I en
dc.contributor.author Labrou, NE en
dc.date.accessioned 2014-06-06T06:48:58Z
dc.date.available 2014-06-06T06:48:58Z
dc.date.issued 2009 en
dc.identifier.issn 15740889 en
dc.identifier.uri http://62.217.125.90/xmlui/handle/123456789/4359
dc.relation.uri http://www.scopus.com/inward/record.url?eid=2-s2.0-78951486927&partnerID=40&md5=040d0e2b717e7092e67f1614ed3c6661 en
dc.subject Detoxification en
dc.subject Enzyme-activated prodrug en
dc.subject Glutathione transferase en
dc.title Glutathione transferases in drug discovery and development: Towards safer and efficacious drugs en
heal.type journalArticle en
heal.publicationDate 2009 en
heal.abstract Glutathione transferases (GSTs) are enzymes involved in cellular detoxification by catalysing the nucleophilic attack of glutathione (GSH) on the electrophilic centre of a number of electrophilic compounds of both endogenous and exogenous origins. This conjugation reaction usually makes the electrophilic substrates more water soluble and, thereby, facilitates their excretion from the body. Determination of metabolic properties of a new chemical entity (NCE) is one of the most important steps during the drug discovery and development process. Nowadays, in vitro methods are used for early estimation and prediction of in vivo metabolism of NCEs. In this review detailed descriptions are given of several biotransformation reactions catalyzed by GSTs that can be used at very early phases of drug development, thereby enabling unsuitable candidates to be eliminated from consideration much earlier in the drug discovery process. Knowledge of the structure-function relationships in classes of compounds that are substrates for GSTs enables the design of molecules that can be stable, or labile which has potential applications in drug and prodrug design. © 2009 Bentham Science Publishers. en
heal.journalName Frontiers in Drug Design and Discovery en
dc.identifier.issue 1 en
dc.identifier.volume 4 en
dc.identifier.spage 23 en
dc.identifier.epage 42 en


Αρχεία σε αυτό το τεκμήριο

Αρχεία Μέγεθος Μορφότυπο Προβολή

Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στην ακόλουθη συλλογή(ές)

Εμφάνιση απλής εγγραφής

Αναζήτηση DSpace


Σύνθετη Αναζήτηση

Αναζήτηση

Ο Λογαριασμός μου

Στατιστικές